Center for Scientific Review; Notice of Closed Meetings, 67883-67884 [06-9384]

Download as PDF Federal Register / Vol. 71, No. 226 / Friday, November 24, 2006 / Notices Dated: November 16, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–9385 Filed 11–22–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: November 16, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–9382 Filed 11–22–06; 8:45 am] BILLING CODE 4140–01–M National Institutes of Health cprice-sewell on PROD1PC66 with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Revised Unsolicited Complement Program Project Review. Date: December 12, 2006. Time: 1 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Room 3118, Bethesda, MD 20817, (Telephone Conference Call). Contact Person: Quirjin Vos, PhD, Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, NIAID/NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892, 301–451–2666, qvos@niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Clinical Trial for Community-Acquired Methicillin Resistant Staphylococcus Aureus Infections. Date: December 18, 2006. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate contract proposals. Place: Holiday Inn Georgetown, 2101 Wisconsin Avenue, NW., Washington, DC 20007. Contact Person: Lynn Rust, PhD., Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892, 301–402–3938, lr228v@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Alergy, Immunology, 13:24 Nov 22, 2006 Dated: November 16, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–9387 Filed 11–22–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings VerDate Aug<31>2005 67883 Jkt 211001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Notice of Closed Meeting Notice is hereby given of a change in the meeting of the National Institute on Aging Special Emphasis Panel, December 4, 2006, 7 p.m. to December 5, 2006 6 p.m. Holiday Inn Chevy Chase, 5520 Wisconsin Avenue, Chevy Chase, MD 20815 which was published in the Federal Register on November 3, 2006, Vol. 71/64730. The meeting will now be held at the Hilton San Diego Airport Hotel, San Diego, California from December 4–5, 2006. The meeting is closed to the public. Dated: November 16, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–9386 Filed 11–22–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director, National Institutes of Health; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Recombinant DNA Advisory Committee, December 5, 2006, 8 a.m. to December 6, 2006, 6 p.m., National Institutes of Health, Building 31, 31 Center Drive, Bethesda, MD 20892 which was published in the Federal Register on November 13, 2006, 71 FR 218, page 66180. The meeting of the Recombinant DNA Advisory Committee will begin on December 5 at 12 noon and will end December 6, 2006 at 6 p.m. instead of 8 a.m. to 6 p.m. The meeting is open to the public. PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel, Member Conflict: Skeletal Muscle and Exercise Physiology. Date: November 28, 2006. Time: 1 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: John P. Holden, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4016J, MSC 7814, Bethesda, MD 20892, 301–496– 8551. holdenjo@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel, Clinical Neuroscience and Disease. Date: November 28, 2006. Time: 3 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Rene Etcheberrigaray, MD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5196, MSC 7846, Bethesda, MD 20892, (301) 435– 1246, etcheber@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing E:\FR\FM\24NON1.SGM 24NON1 cprice-sewell on PROD1PC66 with NOTICES 67884 Federal Register / Vol. 71, No. 226 / Friday, November 24, 2006 / Notices limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel, SBSR Overflow. Date: November 29, 2006. Time: 1:30 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Mehrdad M. Tondravi, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4108, MSC 7814, Bethesda, MD 20892, 301–435– 1173, tondravm@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel, Skeletal Cell Biology. Date: November 30, 2006. Time: 2 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: John P. Holden, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4016J, MSC 7814, Bethesda, MD 20892, 301–496– 8551, holdenjo@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel, Kawasaki. Date: November 30, 2006. Time: 2:20 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Russell T. Dowell, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4128, MSC 7814, Bethesda, MD 20892, 301–435– 1850, dowellr@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel, Gap Junctions, Receptor Modulation and Gene Regulation. Date: December 8, 2006. Time: 2 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Geoffrey G. Schofield, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of VerDate Aug<31>2005 13:24 Nov 22, 2006 Jkt 211001 Health, 6701 Rockledge Drive, Room 4040–A, MSC 7850, Bethesda, MD 20892, 301–435– 1235, geoffreys@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Nanotechnology and Computational Biophysics. Date: December 14, 2006. Time: 4 p.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: John L. Bowers, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4170–A, MSC 7806, Bethesda, MD 20892, 301–435– 1725, bowersj@csr.nih.gov. the Chief Privacy Officer of the Department of Homeland Security (DHS) approved and published ten Privacy Impact Assessments (PIAs) on the DHS Privacy Office Web site, https:// www.dhs.gov/privacy, under the link for ‘‘Privacy Impact Assessments.’’ Below is a short summary of each of those systems, indicating the DHS component responsible for the system, and the date on which the PIA was approved. Additional information can be found on the web site or by contacting the Privacy Office. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: November 16, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–9384 Filed 11–22–06; 8:45 am] July 12, 2006: The objective of RSP is to develop a credible ‘‘response package’’ that could be quickly and efficiently implemented in response to an event or as the result of intelligence indicating a possible threat exists where explosives would be used in a commuter rail or mass transit venue. The RSP is divided into two phases. Phase I, conducted in February 2006, did not require the collection of personally identifiable information and evaluated existing countermeasures using aviation security methods that could be implemented immediately. Phase II is evaluating emerging technologies with varying technological maturity. BILLING CODE 4140–01–M DEPARTMENT OF HOMELAND SECURITY [Docket Number DHS 2006–0071] Privacy Office; Privacy Impact Assessments Approved between June 1, 2006 and September 30, 2006 Privacy Office, Office of the Secretary, Department of Homeland Security. ACTION: Notice of Publication of Privacy Impact Assessments. AGENCY: SUMMARY: The Privacy Office of the Department of Homeland Security is making available ten Privacy Impact Assessments on various programs and systems in the Department. These assessments were approved and published on the Privacy Office’s Web site between June 1, 2006 and September 30, 2006. DATES: The Privacy Impact Assessments will be available on the DHS Web site until at least January 23, 2007, after which they may be obtained by contacting the DHS Privacy Office. FOR FURTHER INFORMATION CONTACT: Hugo Teufel III, Chief Privacy Officer, Department of Homeland Security, Washington, DC 20528; by telephone (571) 227–3813, facsimile (571) 227– 4171, or e-mail: privacy@dhs.gov. SUPPLEMENTARY INFORMATION: Between June 1, 2006 and September 30, 2006, PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 1. Rail Security Pilot Study Phase II (RSP) Science and Technology Directorate 2. US-Visit Update United States Visitor And Immigrant Status Indicator Technology Program (US-VISIT) July 12, 2006: This is an update to previous US-VISIT PIAs in order to describe the expansion of the program’s biometric collection requirements. The expanded biometric requirements cover additional classes of aliens in conjunction with the Notice of Proposed Rulemaking on the Authority to Process Additional Aliens in US-VISIT. 3. Automated Commercial Environment (ACE) e-Manifest: Trucks and International Trade Data System (ITDS) U.S. Customs And Border Protection (CBP) July 14, 2006: CBP is engaged in a multi-year modernization effort to update its information systems. The purposes of ACE are to: streamline business processes; facilitate growth in trade; ensure cargo security; provide means to combat terrorism through monitoring what materials and which persons enter and leave the country; and foster participation in global commerce, while ensuring compliance with U.S. E:\FR\FM\24NON1.SGM 24NON1

Agencies

[Federal Register Volume 71, Number 226 (Friday, November 24, 2006)]
[Notices]
[Pages 67883-67884]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-9384]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Member Conflict: Skeletal Muscle and Exercise Physiology.
    Date: November 28, 2006.
    Time: 1 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: John P. Holden, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4016J, MSC 7814, Bethesda, MD 
20892, 301-496-8551. holdenjo@csr.nih.gov.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Clinical Neuroscience and Disease.
    Date: November 28, 2006.
    Time: 3 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Rene Etcheberrigaray, MD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5196, MSC 7846, Bethesda, MD 
20892, (301) 435-1246, etcheber@csr.nih.gov.
    This notice is being published less than 15 days prior to the 
meeting due to the timing

[[Page 67884]]

limitations imposed by the review and funding cycle.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, SBSR Overflow.
    Date: November 29, 2006.
    Time: 1:30 p.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Mehrdad M. Tondravi, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4108, MSC 7814, Bethesda, MD 
20892, 301-435-1173, tondravm@csr.nih.gov.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Skeletal Cell Biology.
    Date: November 30, 2006.
    Time: 2 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: John P. Holden, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4016J, MSC 7814, Bethesda, MD 
20892, 301-496-8551, holdenjo@csr.nih.gov.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Kawasaki.
    Date: November 30, 2006.
    Time: 2:20 p.m. to 3:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Russell T. Dowell, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4128, MSC 7814, Bethesda, MD 
20892, 301-435-1850, dowellr@csr.nih.gov.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Gap Junctions, Receptor Modulation and Gene Regulation.
    Date: December 8, 2006.
    Time: 2 p.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Geoffrey G. Schofield, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4040-A, MSC 7850, Bethesda, MD 
20892, 301-435-1235, geoffreys@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Nanotechnology and Computational Biophysics.
    Date: December 14, 2006.
    Time: 4 p.m. to 5:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: John L. Bowers, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4170-A, MSC 7806, Bethesda, MD 
20892, 301-435-1725, bowersj@csr.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: November 16, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-9384 Filed 11-22-06; 8:45 am]
BILLING CODE 4140-01-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.